Notice Regarding Continuous Use of Fujifilm X100 To our valued customers Thank you very much for purchasing and using our products. When the X100V is used in a continuous manner (such as with continuous video shooting) or when used in a high temperature environment or direct sun light, a user may feel the grip become […]
Fujifilm is moving quickly into phase III clinical trials of Avigan Tablets for COVID-19 and they are committed to increasing production. We have been covering this “wonder drug” for a while now ( 1, 2, 3, 4, 5, 6) and every day there seems to be more positive news about Avigan now. For those unaware here are the IV levels […]
Fujifilm wins the internationally prestigious Red Dot Design Award with 23 products – In recognition of good design quality and functionality in products of various business fields – High precision lens film for inkjet printing is awarded the “Innovative Product Award,” given to products with outstanding innovation potential TOKYO, March 31, 2020 — FUJIFILM Corporation […]
Western media is starting to catch up with Fujifilm Avigan coverage while Asian media has been almost exclusively covering the wonder drug. Fiercepharma published some more information about Avigan (favipiravir) based on a report by Nikkei Asian Review that gives some insight into how the drug works for those interested. Fujifilm also released a statement […]
We have been reporting about Avigan for a while now 1, 2, 3, 4 now Fujifilm has released more information about their Avigan Tablet in Relation to Covid-19 that you can read about below. Information of Avigan Tablet in Relation to Covid-19 FUJIFILM Corporation delivers correct information regarding the Avigan Tablet developed by FUJIFILM Toyama […]
The world is slowly grinding to a halt and photography is the last thing on most people’s minds, but it is interesting the Fujifilm is playing an increasingly larger roll in treating the Coronavirus (COVID-19) pandemic. FujiAddict has followed the progress of Avigan being used to treat Coronavirus, which started here and here. Today Nikkei […]
